サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1765405

マイクロ流体デバイスシステムの世界市場

Microfluidic Device Systems

出版日
ページ情報
英文 214 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=150.05円
マイクロ流体デバイスシステムの世界市場
出版日: 2025年07月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 214 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

マイクロ流体デバイスシステムの世界市場は2030年までに210億米ドルに達する見込み

2024年に73億米ドルと推定されるマイクロ流体デバイスシステムの世界市場は、2024年から2030年にかけてCAGR 19.3%で成長し、2030年には210億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである体外診断薬は、CAGR19.3%を記録し、分析期間終了時には133億米ドルに達すると予測されます。医薬品セグメントの成長率は、分析期間中CAGR 16.7%と推定されます。

米国市場は21億米ドルと推定、中国はCAGR18.8％で成長予測

米国のマイクロ流体デバイスシステム市場は、2024年に21億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに33億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは18.8%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ16.9%と16.1%と予測されています。欧州では、ドイツがCAGR約13.2%で成長すると予測されています。

世界のマイクロ流体デバイスシステム市場- 主要動向と促進要因まとめ

マイクロ流体デバイスシステムとは何か、なぜ現代のバイオメディカルおよび産業アプリケーションで重要なのか？

マイクロ流体デバイスシステムとは、チップ上にエッチングされた流路を通して少量の流体（通常マイクロリットルまたはナノリットルの範囲）を操作し、化学的、生物学的、物理的プロセスの精密な制御を可能にする小型化されたプラットフォームです。これらのデバイスは、ポンプ、バルブ、センサー、ミキサーなどのコンポーネントを統合し、診断、ドラッグデリバリー、化学分析、環境モニタリングなど、さまざまなアプリケーションを可能にします。マイクロ流体工学は、処理の高速化、試薬消費量の削減、低コスト化、感度の向上などの利点を提供し、ヘルスケア、医薬品、食品安全、研究などの分野で重要な技術となっています。

マイクロ流体デバイスシステムの重要性は、迅速、正確、かつ費用対効果の高い流体の分析と合成を提供する能力にあり、ポイントオブケア診断、ラボオンチップ技術、ハイスループットスクリーニングの進歩を可能にします。実験室のプロセスを小型化することで、マイクロ流体工学は個別化医療、効率的な創薬、リアルタイムの環境モニタリングをサポートします。産業界がより高い精度、より優れた自動化、より持続可能なプロセスを目指す中、マイクロ流体システムは現代の生物医学研究、臨床診断、産業アプリケーションにおいて不可欠なツールとなっています。

技術の進歩はマイクロ流体デバイスシステム市場をどのように形成しているか？

技術の進歩は、マイクロ流体デバイスシステムの精度、汎用性、統合能力を著しく向上させ、多様なアプリケーションにおけるイノベーションを促進しています。PDMS（ポリジメチルシロキサン）、ガラス、環状オレフィンコポリマー（COC）など、生体適合性、耐薬品性、光学的透明性を向上させる先端材料の使用が、その大きな開発のひとつです。これらの材料はマイクロ流体デバイスの性能と信頼性を高め、複雑なアッセイ、ドラッグデリバリーシステム、リアルタイム診断に適しています。

自動制御システムの統合は、マイクロ流体デバイスの機能性をさらに向上させました。自動化されたプラットフォームには、センサー、アクチュエーター、ソフトウェアが組み込まれており、流体の流れ、温度、圧力をリアルタイムでモニターし、操作することができます。この機能は、電気信号を使ってチップ上の微小液滴を操作し、迅速で精密な生化学アッセイを可能にするデジタル・マイクロ流体工学のようなアプリケーションでは極めて重要です。自動化は、スループットと精度を向上させるだけでなく、人間の介入を減らし、マイクロ流体システムをよりスケーラブルにし、産業界のニーズに適応させる。

3Dプリンティングと微細加工技術の進歩は、マイクロ流体デバイスの設計の可能性を広げました。3Dプリンティングは、複雑なマイクロ流体構造の迅速なプロトタイピングを可能にし、診断、医薬品開発、環境試験などの特定の用途向けにカスタマイズされたデバイス設計をサポートします。ソフトリソグラフィやフォトリソグラフィなどの微細加工における技術革新は、マイクロ流体チップ内のコンポーネントの小型化と統合を改善し、複数の分析機能を1つのデバイスに統合したラボオンチップデバイスの開発を可能にしました。このような技術革新は、マイクロ流体システムの能力を拡大するだけでなく、バイオメディカルや工業プロセスにおける小型化、自動化、高精度化という幅広い動向にも合致しています。

さまざまな分野でのマイクロ流体デバイスシステムの新たな応用例とは？

マイクロ流体デバイスシステムは、高精度で費用対効果が高く、迅速な分析ツールへのニーズに後押しされ、様々な分野で応用が広がっています。ヘルスケア分野では、マイクロ流体工学はポイント・オブ・ケア診断に広く使用されており、感染症、がん、心血管疾患などの疾患の迅速な検査を可能にしています。サンプル調製、反応、検出を1つのチップ上に統合したラボオンチップ・デバイスは、血液検査、グルコース・モニタリング、遺伝子分析に使用され、個別化医療や病気の早期発見をサポートしています。マイクロ流体デバイスはまた、薬効や病気の進行をテストするために人間の臓器機能をシミュレートするorgan-on-a-chipモデルにも使用され、動物モデルへの依存を減らし、医薬品開発を加速しています。

製薬業界では、マイクロ流体工学は創薬と開発において重要な役割を果たしています。マイクロ流体は、薬剤候補のハイスループット・スクリーニング、ナノ医薬品の効率的な合成、ドラッグ・デリバリー・システムの制御を可能にします。マイクロ流体プラットフォームにより、研究者は迅速なアッセイ、細胞レベルでの薬物相互作用の研究、サイズや組成を正確に制御したリポソームやナノ粒子のような複雑な製剤の作成を行うことができます。このような機能により、薬効が向上し、副作用が減少し、開発期間が短縮されるため、マイクロ流体工学は現代の医薬品研究に欠かせないものとなっています。

環境分野では、水質、土壌分析、汚染物質の検出のリアルタイム・モニタリングにマイクロ流体デバイスが使用されています。重金属、病原体、農薬などの汚染物質の迅速なオンサイト検査が可能になり、環境保護と持続可能な管理の取り組みをサポートしています。飲食品業界では、マイクロ流体システムが品質管理のために採用され、食品中の病原体、アレルゲン、化学汚染物質を検出しています。迅速かつ正確な結果を提供できるマイクロ流体システムは、食品の安全性を確保し、規制基準を遵守するための貴重なツールです。これらの分野でマイクロ流体デバイスシステムの用途が拡大していることは、消費者向けと産業向けの両分野において、正確で効率的かつ拡張性のある分析ソリューションを実現する上で、マイクロ流体デバイスシステムが重要な役割を担っていることを浮き彫りにしています。

マイクロ流体デバイスシステム市場の成長の原動力は？

マイクロ流体デバイスシステム市場の成長は、迅速診断に対する需要の増加、精密医療の進歩、創薬や環境モニタリングにおける採用の増加など、いくつかの要因によってもたらされます。主な成長要因の1つは、ポイントオブケア診断と分散型ヘルスケアソリューションの世界の推進です。ヘルスケアプロバイダーがアクセス改善、コスト削減、迅速な結果提供を目指している中、マイクロ流体システムはベッドサイド、診療所、遠隔地で検査を実施するためのスケーラブルなソリューションを提供します。小型で迅速なターンアラウンドと最小限のサンプル要件は、迅速な疾患スクリーニングとモニタリングに理想的です。

個別化医療が重視されるようになり、マイクロ流体デバイスシステムの需要はさらに高まっています。精密医療では、個々の遺伝的、環境的、生活習慣的要因に基づいたオーダーメイドの治療計画が必要とされるため、マイクロ流体デバイスは遺伝子解析やバイオマーカー解析の効率的な処理を可能にし、個別化治療の選択やモニタリングをサポートします。この需要は、個別化治療アプローチが患者の転帰に不可欠な腫瘍学、感染症、代謝性疾患などの分野で特に強いです。

創薬および薬剤開発の進歩も、マイクロ流体デバイスの採用に寄与しています。製薬会社は、薬剤候補のハイスループット・スクリーニング、迅速な製剤化、試験にマイクロ流体プラットフォームを使用し、開発時間とコストを削減しています。混合、反応、検出など複数の機能を1つのデバイスに統合できるため、より効率的なワークフローが可能になり、医薬品研究やバイオ製造におけるマイクロ流体の魅力が高まっています。

環境モニタリングのニーズが高まり、水、土壌、食品の安全性に関する規制が強化されたことで、汚染物質や病原体を迅速に検出するためのマイクロ流体デバイスの利用が進んでいます。携帯性、精度、試薬消費量の少なさから、先進国市場でも新興市場でもリアルタイム・モニタリングに効果的なツールとなっており、持続可能な管理と規制遵守を支えています。

材料、小型化、統合技術における技術革新の進行により、マイクロ流体デバイスシステム市場は力強い成長の態勢を整えています。これらの動向は、迅速で正確かつコスト効率の高い分析ソリューションに対する需要の高まりと相まって、マイクロ流体工学を、ヘルスケアの改善、医薬品開発の加速、さまざまな分野における持続可能な実践の支援に焦点を当てた現代的戦略の重要な要素にしています。

セグメント

アプリケーション（POC検査、製薬・ライフサイエンス調査、ドラッグデリバリー、分析機器、臨床・獣医診断、環境・産業）、産業（体外診断、製薬、医療機器）

調査対象企業の例

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Dolomite Microfluidics
  • Fluidigm Corporation
  • Johnson & Johnson
  • Micronit Microtechnologies B.V.
  • RainDance Technologies, Inc.
  • Roche Diagnostics（Schweiz）AG
  • Siemens Healthineers

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP16590

Global Microfluidic Device Systems Market to Reach US$21.0 Billion by 2030

The global market for Microfluidic Device Systems estimated at US$7.3 Billion in the year 2024, is expected to reach US$21.0 Billion by 2030, growing at a CAGR of 19.3% over the analysis period 2024-2030. In-vitro diagnostics, one of the segments analyzed in the report, is expected to record a 19.3% CAGR and reach US$13.3 Billion by the end of the analysis period. Growth in the Pharmaceuticals segment is estimated at 16.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 18.8% CAGR

The Microfluidic Device Systems market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.3 Billion by the year 2030 trailing a CAGR of 18.8% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 16.9% and 16.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global Microfluidic Device Systems Market - Key Trends & Drivers Summarized

What Are Microfluidic Device Systems, and Why Are They So Crucial in Modern Biomedical and Industrial Applications?

Microfluidic Device Systems are miniaturized platforms that manipulate small volumes of fluids (typically in the microliter or nanoliter range) through channels etched on a chip, enabling precise control of chemical, biological, and physical processes. These devices integrate components like pumps, valves, sensors, and mixers, allowing for various applications such as diagnostics, drug delivery, chemical analysis, and environmental monitoring. Microfluidics offers advantages like faster processing, reduced reagent consumption, lower costs, and improved sensitivity, making it a key technology in sectors like healthcare, pharmaceuticals, food safety, and research.

The importance of microfluidic device systems lies in their ability to provide rapid, accurate, and cost-effective analysis and synthesis of fluids, enabling advancements in point-of-care diagnostics, lab-on-a-chip technologies, and high-throughput screening. By miniaturizing laboratory processes, microfluidics supports personalized medicine, efficient drug discovery, and real-time environmental monitoring. As industries aim for higher precision, better automation, and more sustainable processes, microfluidic systems have become essential tools in modern biomedical research, clinical diagnostics, and industrial applications.

How Are Technological Advancements Shaping the Microfluidic Device Systems Market?

Technological advancements have significantly enhanced the precision, versatility, and integration capabilities of Microfluidic Device Systems, driving innovation across diverse applications. One of the major developments is the use of advanced materials, such as PDMS (polydimethylsiloxane), glass, and cyclic olefin copolymers (COCs), which offer improved biocompatibility, chemical resistance, and optical transparency. These materials enhance the performance and reliability of microfluidic devices, making them suitable for complex assays, drug delivery systems, and real-time diagnostics.

The integration of automated control systems has further improved the functionality of microfluidic devices. Automated platforms incorporate sensors, actuators, and software that enable real-time monitoring and manipulation of fluid flow, temperature, and pressure. This capability is crucial in applications like digital microfluidics, where electrical signals are used to manipulate tiny droplets on a chip, enabling rapid and precise biochemical assays. Automation not only increases throughput and accuracy but also reduces human intervention, making microfluidic systems more scalable and adaptable to industrial needs.

Advancements in 3D printing and microfabrication techniques have expanded the design possibilities of microfluidic devices. 3D printing allows for rapid prototyping of complex microfluidic structures, supporting customized device designs for specific applications in diagnostics, drug development, and environmental testing. Innovations in microfabrication, such as soft lithography and photolithography, have improved the miniaturization and integration of components within microfluidic chips, enabling the development of lab-on-a-chip devices that combine multiple analytical functions in a single device. These technological innovations not only expand the capabilities of microfluidic systems but also align with broader trends toward miniaturization, automation, and precision in biomedical and industrial processes.

What Are the Emerging Applications of Microfluidic Device Systems Across Different Sectors?

Microfluidic Device Systems are finding expanding applications across various sectors, driven by the need for high-precision, cost-effective, and rapid analytical tools. In the healthcare sector, microfluidics is widely used in point-of-care diagnostics, enabling rapid tests for conditions like infectious diseases, cancer, and cardiovascular disorders. Lab-on-a-chip devices, which integrate sample preparation, reaction, and detection on a single chip, are used for blood testing, glucose monitoring, and genetic analysis, supporting personalized medicine and early disease detection. Microfluidic devices are also used in organ-on-a-chip models, which simulate human organ functions to test drug effects and disease progression, reducing the reliance on animal models and accelerating drug development.

In the pharmaceutical industry, microfluidics plays a critical role in drug discovery and development. It enables high-throughput screening of drug candidates, efficient synthesis of nanomedicines, and controlled drug delivery systems. Microfluidic platforms allow researchers to perform rapid assays, study drug interactions at the cellular level, and create complex formulations like liposomes and nanoparticles with precise control over size and composition. These capabilities enhance drug efficacy, reduce side effects, and shorten development timelines, making microfluidics indispensable in modern drug research.

In the environmental sector, microfluidic devices are used for real-time monitoring of water quality, soil analysis, and detection of pollutants. They enable rapid, on-site testing for contaminants like heavy metals, pathogens, and pesticides, supporting efforts in environmental protection and sustainable management. In the food and beverage industry, microfluidic systems are employed for quality control, detecting pathogens, allergens, and chemical contaminants in food products. Their ability to provide quick and accurate results makes them valuable tools for ensuring food safety and compliance with regulatory standards. The expanding applications of microfluidic device systems across these sectors highlight their critical role in enabling precise, efficient, and scalable analytical solutions in both consumer and industrial settings.

What Drives Growth in the Microfluidic Device Systems Market?

The growth in the Microfluidic Device Systems market is driven by several factors, including increasing demand for rapid diagnostics, advancements in precision medicine, and rising adoption in drug discovery and environmental monitoring. One of the primary growth drivers is the global push for point-of-care diagnostics and decentralized healthcare solutions. As healthcare providers aim to improve access, reduce costs, and deliver faster results, microfluidic systems offer a scalable solution for performing tests at the bedside, in clinics, or in remote locations. Their small size, rapid turnaround, and minimal sample requirements make them ideal for quick disease screening and monitoring.

The growing emphasis on personalized medicine has further fueled demand for microfluidic device systems. As precision medicine requires tailored treatment plans based on individual genetic, environmental, and lifestyle factors, microfluidic devices enable efficient processing of genetic and biomarker analyses, supporting personalized therapy selection and monitoring. This demand is particularly strong in fields like oncology, infectious diseases, and metabolic disorders, where individualized treatment approaches are critical for patient outcomes.

Advancements in drug discovery and development have also contributed to the adoption of microfluidic devices. Pharmaceutical companies use microfluidic platforms for high-throughput screening, rapid formulation, and testing of drug candidates, reducing development time and costs. The ability to integrate multiple functions, such as mixing, reaction, and detection, in a single device supports more efficient workflows, increasing the appeal of microfluidics in drug research and biomanufacturing.

Rising environmental monitoring needs and stricter regulations for water, soil, and food safety have driven the use of microfluidic devices for rapid detection of contaminants and pathogens. Their portability, accuracy, and low reagent consumption make them effective tools for real-time monitoring in both developed and emerging markets, supporting sustainable management and regulatory compliance.

With ongoing innovations in materials, miniaturization, and integration technologies, the microfluidic device systems market is poised for robust growth. These trends, combined with increasing demand for rapid, accurate, and cost-effective analytical solutions, make microfluidics a vital component of modern strategies focused on improving healthcare, accelerating drug development, and supporting sustainable practices across various sectors.

SCOPE OF STUDY:

The report analyzes the Microfluidic Device Systems market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Point of Care Testing, Pharmaceutical and Life Science Research, Drug Delivery, Analytical Devices, Clinical and Veterinary Diagnostics, Environment and Industrial); Industry (In-vitro Diagnostics, Pharmaceuticals, Medical Devices)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 23 Featured) -

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson & Company
  • Bio-Rad Laboratories, Inc.
  • Cepheid, Inc.
  • Dolomite Microfluidics
  • Fluidigm Corporation
  • Johnson & Johnson
  • Micronit Microtechnologies B.V.
  • RainDance Technologies, Inc.
  • Roche Diagnostics (Schweiz) AG
  • Siemens Healthineers

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Microfluidic Device Systems - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Point-of-Care Diagnostics Drives Microfluidic Device Adoption
    • Advancements in Lab-on-a-Chip Technology Propel Market Growth
    • Increasing Use in Drug Discovery Expands Microfluidics Market Opportunities
    • Miniaturization of Medical Devices Strengthens Business Case for Microfluidics
    • Expanding Use in Genomics and Proteomics Sets the Stage for Growth
    • Strong Demand for Rapid Testing During Disease Outbreaks Generates Demand
    • Use in Cell Analysis and Manipulation Expands Addressable Market
    • Growing Focus on Organ-on-Chip Technology Drives Microfluidics Adoption
    • Expanding Applications in Food Safety Testing Spur Microfluidic Adoption
    • Growing Use in Environmental Monitoring Generates Demand for Devices
    • Rising Focus on Microfluidics in Biopharmaceutical Production Sustains Growth
    • Increasing Demand for Home Healthcare Devices Sets the Stage for Microfluidics Expansion
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Microfluidic Device Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Microfluidic Device Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Microfluidic Device Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for In-vitro diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for In-vitro diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for In-vitro diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Pharmaceuticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Pharmaceuticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Point of care testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Point of care testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Point of care testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Pharmaceutical and life science research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Pharmaceutical and life science research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Pharmaceutical and life science research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Drug delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Drug delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Drug delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Analytical devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Analytical devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Analytical devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Clinical and veterinary diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Clinical and veterinary diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Clinical and veterinary diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Environment and Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Environment and Industrial by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Environment and Industrial by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • JAPAN
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • CHINA
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • EUROPE
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Microfluidic Device Systems by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Microfluidic Device Systems by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • FRANCE
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • GERMANY
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Microfluidic Device Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for Microfluidic Device Systems by Industry - In-vitro diagnostics, Pharmaceuticals and Medical Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of World 15-Year Perspective for Microfluidic Device Systems by Industry - Percentage Breakdown of Value Sales for In-vitro diagnostics, Pharmaceuticals and Medical Devices for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for Microfluidic Device Systems by Application - Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of World 15-Year Perspective for Microfluidic Device Systems by Application - Percentage Breakdown of Value Sales for Point of care testing, Pharmaceutical and life science research, Drug delivery, Analytical devices, Clinical and veterinary diagnostics and Environment and Industrial for the Years 2015, 2025 & 2030

IV. COMPETITION